Oligonucleotide Synthesis Market Synopsis
The chemical synthesis of the nucleic acids with definite chemical structures is known as oligonucleotide synthesis. Its ability to produce results regarding customized nucleotides rapidly through inexpensive methods is making it choicest preference for a lot of research laboratories that are spending heavily in developing biotechnologies.
The major factors identified as the positive drivers of the market are rising investment by the government for the research and development of genomic technologies, high rate of demand for innovation in the field of life science and medical academics, rapid-paced advancements in the healthcare sector, and increasing demand for oligonucleotide synthesis technologies by both public and private research firms.
The Global Oligonucleotide Synthesis Market is projected to attain a compound annual growth rate of around 10.3% during the forecast period between 2016 and 2022.
Avail FREE Sample Here: https://www.marketresearchfuture.com/sample_request/2337
Moreover, an increasing number of applications of oligonucleotide synthesis in genetic testing, therapeutics, gene synthesis, diagnostic, research, library preparation, drug target screening, and others is further strengthening the growth of the global market.
Major Key Players Competitive Landscapes
The players in the market are coming-up with new solutions and services and are continuously striving for development. The global oligonucleotide synthesis market includes a number of key players, including –
Bioautomation Corporation (U.S.)
GE Healthcare (U.S.)
Integrated DNA Technologies Inc (U.S)
Thermo Fisher Scientific Inc. (U.S.)
Nitto Denko Avecia Inc. (Japan)
Agilent Technologies Inc. (U.S.)
L.G.C Biosearch Technologies (U.S.)
Sigma-Aldrich Corporation (U.S.)
Eurogentec S.A (Belgium)
Eurofins Genomics (Germany)
and others.
Market Segmentation
The global oligonucleotide synthesis market segmentation is done on the basis of application, product type, and end-users.
By application, the market includes drug target screening, library preparation, genetic testing, therapeutics, diagnostic, gene synthesis, research, and others. The Drug target screening segment holds the largest share due to the massive traction it receives from the pharmaceutical sector.
By end-users, the market includes diagnostic laboratories, academic research institutes, and pharmaceutical & biotechnology companies. Diagnostic laboratories segment is calculated to record massive growth during the forecast period.
By product type, the market includes reagents, synthesized oligonucleotides, and equipment. The synthesized oligonucleotides segment boasts an impressive hold over the global market.
Regional Analysis
The geographical segmentation of the global oligonucleotide synthesis market covers regions like Asia Pacific, Europe, North America, and the Middle East & Africa (MEA).
Browse Complete Premium Research details along with the TOC at: https://www.marketresearchfuture.com/reports/oligonucleotide-synthesis-market-2337
North America leads the global charts with the highest share of the market. The regional market is further expected to expand in the forthcoming years primarily due to the constant search for better treatments. The robust and developed healthcare structure and infrastructure of the research centers are indicative of the constant efforts put-in to fulfill this need. The region is also driven by the prevalence of chronic diseases like cancer and diabetes. Additionally, both government and private investors are providing constant funding to bring-forward innovation and development into the sector. This is also steering the market growth of North America forward.
Europe holds the second spot in the global market standings of oligonucleotide synthesis. The regional market herein is driven by the same intent as that of North America and is amply backed by government initiatives and research centers. The regional market is aided with investments from various pharmaceutical companies in order to understand the gene sequencing to develop improved drugs. The Asia Pacific region is anticipated to significantly rise in the forthcoming years as many of the leading players in the global market see the region as a massive scope of investment opportunity. Herein, infrastructural benefits and the pricing of resources are some of the most important factors that are stimulating a positive growth of the market.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Comments
Post a Comment